StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Investment analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Wednesday. The firm set a “hold” rating on the stock.

Milestone Scientific Price Performance

MLSS opened at $0.96 on Wednesday. The firm has a market capitalization of $74.49 million, a PE ratio of -13.66 and a beta of 1.12. The business’s 50-day moving average is $1.01 and its two-hundred day moving average is $0.96. Milestone Scientific has a 1 year low of $0.54 and a 1 year high of $1.39.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of MLSS. Renaissance Technologies LLC grew its holdings in Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares during the last quarter. Carnegie Investment Counsel boosted its position in shares of Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares in the last quarter. World Investment Advisors LLC purchased a new position in Milestone Scientific during the 3rd quarter worth $91,000. Geode Capital Management LLC increased its position in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in Milestone Scientific during the 3rd quarter valued at about $48,000. Institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.